The Pros1/Tyro3 axis protects against periodontitis by modulating STAT/SOCS signalling. Issue 4 (7th February 2019)

• Record Type: Journal Article
• Authors: Jiang, Lei; Chen, Xiao Qing; Gao, Ming Jing; Lee, Wai; Zhou, Jie; Zhao, Yun Fu; Wang, Guo Dong
• Is Part Of: Journal of cellular and molecular medicine. Volume 23:Issue 4(2019)
• Page Start: 2769
• Page End: 2781
• Publication Date: 2019-02-07
• Subjects: periodontitis -- Pros1 -- SOCS1/3 -- STAT1/3 -- Tyro3; Cytology; Medicine; Molecular Biology; Cytologie -- Périodiques; Médecine -- Périodiques; Biologie moléculaire -- Périodiques; Cytology -- Periodicals; Medicine -- Periodicals; Molecular biology -- Periodicals; 611.01805
• DOI: 10.1111/jcmm.14183
• Languages: English
• ISSNs: 1582-1838

Abstract

Abstract: Periodontitis, an oral inflammatory disease caused by periodontal pathogen infection, is the most prevalent chronic inflammatory disease and a major burden on healthcare. The TAM receptor tyrosine kinases (Tyro3, Axl and Mertk) and their ligands (Gas6 and Pros1) play a pivotal role in the resolution of inflammation and have been associated with chronic inflammatory and autoimmune diseases. In this study, we evaluated the effects of exogenous Pros1 in in vitro and in vivo models of periodontitis. We detected higher Pros1 but lower Tyro3 levels in inflamed gingival specimens of periodontitis patients compared with healthy controls. Moreover, Pros1 was mostly localized in the gingival epithelium of all specimens. In cultured human gingival epithelial cells (hGECs), Porphyromonas gingivalis LPS ( p.g ‐LPS) stimulation down‐regulated Pros1 and Tyro3. Exogenous Pros1 inhibited p.g ‐LPS–induced production of TNF‐α, IL‐6, IL‐1β, MMP9/2 and RANKL in a Tyro3‐dependent manner as revealed by PCR, Western blot analysis, ELISA and gelatin zymography. Pros1 also restored Tyro3 expression down‐regulated by p.g ‐LPS in hGECs. In rats treated with ligature and p.g ‐LPS, administration of Pros1 attenuated periodontitis‐associated gingival inflammation and alveolar bone loss. Our mechanistic studies implicated SOCS1/3 and STAT1/3 as mediators of the in vitro and in vivo anti‐inflammatory effects of Pros1. Collectively, the findings from this work supported Pros1 as a novel anti‐inflammatory therapy for periodontitis.